Re: A few thoughts
|
6
|
Resverlogix Corp.
|
Jul 22, 2015 04:18PM
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
3
|
Resverlogix Corp.
|
Sep 26, 2015 07:42AM
|
Re: A Homecoming of Sorts...book value question
|
2
|
Resverlogix Corp.
|
Sep 23, 2015 06:42PM
|
Re: A lot of expectations...???
|
2
|
Resverlogix Corp.
|
Dec 16, 2016 02:12PM
|
Re: A new 52 week low, but I don't think anyone cares....
|
4
|
Resverlogix Corp.
|
Sep 24, 2019 12:37PM
|
Re: A new 52 week low, but I don't think anyone cares....
|
5
|
Resverlogix Corp.
|
Sep 24, 2019 10:11AM
|
Re: A new blog post with RVX mentioned....
|
4
|
Resverlogix Corp.
|
Jul 18, 2016 04:09PM
|
Re: A new blog post with RVX mentioned....
|
5
|
Resverlogix Corp.
|
Jul 18, 2016 11:45AM
|
Re: A new day for RVX
|
2
|
Resverlogix Corp.
|
May 13, 2021 09:28AM
|
Re: A new day for RVX
|
3
|
Resverlogix Corp.
|
May 13, 2021 10:05AM
|
Re: A Shenzhen Hepalink M&A type deal...
|
2
|
Resverlogix Corp.
|
Jan 07, 2018 10:53AM
|
Re: A Shenzhen Hepalink M&A type deal...
|
2
|
Resverlogix Corp.
|
Jan 07, 2018 11:55AM
|
Re: A taxable versus a non taxable sale
|
1
|
Zenith Epigenetics
|
Sep 12, 2018 09:52PM
|
Re: A taxable versus a non taxable sale
|
1
|
Zenith Epigenetics
|
Sep 13, 2018 05:04AM
|
Re: A whole slew of expired options reported at Canadianinsider:
|
1
|
Resverlogix Corp.
|
Jul 14, 2018 12:19PM
|
Re: A whole slew of expired options reported at Canadianinsider:
|
2
|
Resverlogix Corp.
|
Jul 15, 2018 07:26AM
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 23, 2018 12:41PM
|
Re: AACR 2019
|
|
Zenith Epigenetics
|
Feb 28, 2019 06:30AM
|
Re: AACR 2019
|
1
|
Zenith Epigenetics
|
Feb 28, 2019 11:26AM
|
Re: AACR 2019
|
2
|
Zenith Epigenetics
|
Feb 28, 2019 11:46AM
|